Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem.

Massimo CugnoRoberta GualtierottiGiovanni CasazzaFrancesco TafuriGabriele GhigliazzaAdriana TorriGiorgio CostantinoNicola MontanoFlora Peyvandi

Published in: Advances in therapy (2021)

The apparently increased mortality of patients with COVID-19 receiving long-term treatment with ACE inhibitors or ARBs is not due to the drugs themselves, but to the conditions associated with their use.

Keyphrases

cardiovascular events
type diabetes
angiotensin ii
coronary artery disease
replacement therapy
drug induced